Evidence map›Paper›PMID 31245936›Full record

ArticleMolecular genetics & genomic medicine2019

Sleep apnea and the impact on cardiovascular risk in patients with Marfan syndrome.

Laura Muiño-Mosquera, Fré Bauters, Karlien Dhondt, Hans De Wilde, Luc Jordaens, Katya De Groote, Daniel De Wolf, Katrien Hertegonne, Julie De Backer

Open access · goldAbstract read
In one paragraph

Article in Molecular genetics & genomic medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 13 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Assessment of pleural pressure during sleep in Marfan syndrome.Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine · 2022
    Article
  6. Review
  7. Marfan syndrome.Nature reviews. Disease primers · 2021
    Review
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Laura Muiño-MosqueraCentre for Medical Genetics, Ghent University Hospital, Ghent, Belgium.ORCID 0000-0002-3094-7807
Fré BautersDepartment of Pneumology, Ghent University Hospital, Ghent, Belgium.
Karlien DhondtDepartment of Pneumology, Ghent University Hospital, Ghent, Belgium.
Hans De WildeDepartment of Pediatrics, Division of Pediatric Cardiology, Ghent University Hospital, Ghent, Belgium.
Luc JordaensDepartment of Cardiology, Ghent University Hospital, Ghent, Belgium.
Katya De GrooteDepartment of Pediatrics, Division of Pediatric Cardiology, Ghent University Hospital, Ghent, Belgium.
Daniel De WolfDepartment of Pediatrics, Division of Pediatric Cardiology, Ghent University Hospital, Ghent, Belgium.
Katrien HertegonneDepartment of Pneumology, Ghent University Hospital, Ghent, Belgium.
Julie De BackerCentre for Medical Genetics, Ghent University Hospital, Ghent, Belgium.ORCID 0000-0001-8878-1507
Ghent University Hospital · BE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMarfan syndrome (MFS) is an inherited connective tissue disorder characterized by ectopia lentis, aortic root dilation and dissection and specific skeletal features. Obstructive sleep apnea (OSA) in MFS has been described earlier but the prevalence and its relation with the cardiovascular risk is still controversial. This study aimed to further investigate these aspects.

methodsIn this prospective longitudinal study, we performed an attended polysomnography in 40 MFS patients (60% women, 37 ± 12.8 years) and evaluated several cardiovascular parameters through echocardiography, resting electrocardiogram, 24 hr-Holter monitoring and serum NT-ProBNP measurements.

resultsWe found that OSA was present in 42.5% of the patients and that higher body mass index was the most important factor associated with the presence of OSA. We observed that overweight was present in 27.5% of the patients in the whole cohort and in 55.6% if >40 years. Furthermore, when evaluating the impact of OSA on the cardiovascular system, we observed that patients with OSA tended to have higher systolic blood pressure, larger distal aortic diameters and a higher prevalence of ventricular arrhythmia. These differences were, however, not significant after adjusting for confounders.

conclusionsOur study shows a high prevalence of OSA and a high prevalence of overweight in MFS patients. We found some trends between OSA and cardiovascular features but we could not establish a solid association. Our study, however might be underpowered, and a multicenter collaborative study could be very useful to answer some important open questions.

Indexed as

AdipokinesAdultAortic AneurysmAortic DissectionArrhythmias, CardiacBlood PressureBody Mass IndexCardiovascular DiseasesElectrocardiographyFemaleFibrillin-1Genetic Association StudiesHumansMaleMarfan SyndromeMiddle AgedAdipokinesFBN1 protein, humanFibrillin-1Natriuretic Peptide, BrainPeptide Fragmentspro-brain natriuretic peptide (1-76)aortic aneurysmaortic dissectionarrhythmiacardiovascular riskMarfan syndromesleep apnea

Identifiers

PMID31245936
PMCPMC6687621
OpenAlexW2954750600

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.